EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Pan‐Hepatic T‐Cell Atlas Identifies Disease‐Specific Immune Dysfunction and Therapeutic Targets for Immunotherapy

Si-Yuan Chen, You-Yuan Wang, Shuang-Nan Zhou, Ming-Ju Zhou, Xia Li, Wei-Zhe Li, Meng-Meng Zhu, Yu-Xuan Yang, Ying Sun, Peiyao Fan, Jing Li, Xing Fan und 7 weitere

MedComm · 2026-11 · 7 (11)

DOI: 10.1002/mco2.71146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedComm, online erschienen am 08.11.2026. Verfasst von Si-Yuan Chen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Senior Department of Infectious Diseases Chinese PLA General Hospital Beijing China. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Major Project, Beijing Nova Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Single‐cell transcriptomics has greatly advanced insight into hepatic immunity and immunotherapy. However, the absence of an integrated atlas spanning multiple hepatic diseases limits systematic comparisons of immune heterogeneity and dynamics. Here, we established a P an‐ HE patic single‐cell A tlas of T cells (Pheat), covering 139 donors, 255 blood and liver samples spanning chronic hepatitis (chronic hepatitis B/C [CHB/CHC], alcohol‐associated hepatitis, metabolic dysfunction‐associated steatohepatitis), cirrhosis, hepatocellular carcinoma (HCC), and healthy controls (HC), and delineated profound population‐, tissue‐, and disease‐level heterogeneity of 624,215 T cells, with emphasis on CD8 + exhausted T cells (Tex) and CD4 + regulatory T cells (Treg). Within Tex, intrahepatic precursor Tex (Tex pre ) were depleted in CHB compared with healthy controls and other hepatic diseases. Disease‐specific checkpoint dominance (4‐1BB in CHB, TIGIT in HCC) in Tex pre was identified and experimentally validated. Panobinostat was predicted and validated to reinvigorate Tex pre in CHB patients. In parallel, effector Treg (eTreg) accumulated in diseased livers and exhibited divergent IL‐2–STAT5 signaling—hyperactive in CHB and HCC, suppressed in cirrhosis—indicating distinct immunosuppressive status. Lapatinib/olopatadine enhanced Treg suppressive markers in cirrhosis. Pheat provides a high‐resolution atlas of hepatic T cells, revealing disease‐specific immune heterogeneity and regulatory programs that inform cellular and molecular targets for potential immunotherapy.

Schlagwörter

Stichwörter der Autor:innen

cellular and molecular targetsexhausted CD8+ T cellshepatic diseasesregulatory CD4+ T cellssingle‐cell T‐cell atlas

Autor:innen und Institutionen

  • Senior Department of Infectious Diseases Chinese PLA General Hospital Beijing China.
  • National Clinical Research Center for Infectious Diseases Beijing China.
  • The Second School of Clinical Medicine Southern Medical University Guangzhou China.

Förderung

  • National Science and Technology Major Project
  • Beijing Nova Program
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Chen, S. Y., Wang, Y. Y., Zhou, S. N., Zhou, M. J., Li, X., Li, W. Z., Zhu, M. M., Yang, Y. X., Sun, Y., Fan, P., Li, J., Fan, X., Xu, R., Jiao, Y. M., Song, J. W., Zhen, C., Shi, M., Zhang, C., & Wang, F. S. (2026). A Pan‐Hepatic T‐Cell Atlas Identifies Disease‐Specific Immune Dysfunction and Therapeutic Targets for Immunotherapy. MedComm, 7(11). https://doi.org/10.1002/mco2.71146

Vancouver

Chen SY, Wang YY, Zhou SN, Zhou MJ, Li X, Li WZ, et al. A Pan‐Hepatic T‐Cell Atlas Identifies Disease‐Specific Immune Dysfunction and Therapeutic Targets for Immunotherapy. MedComm. 2026;7(11). doi:10.1002/mco2.71146

BibTeX
@article{Chen2026,
  author = {Chen, Si-Yuan and Wang, You-Yuan and Zhou, Shuang-Nan and Zhou, Ming-Ju and Li, Xia and Li, Wei-Zhe and Zhu, Meng-Meng and Yang, Yu-Xuan and Sun, Ying and Fan, Peiyao and Li, Jing and Fan, Xing and Xu, Ruonan and Jiao, Yan-Mei and Song, Jin-Wen and Zhen, Cheng and Shi, Ming and Zhang, Chao and Wang, Fu-Sheng},
  title = {A Pan‐Hepatic T‐Cell Atlas Identifies Disease‐Specific Immune Dysfunction and Therapeutic Targets for Immunotherapy},
  journal = {MedComm},
  year = {2026},
  volume = {7},
  number = {11},
  doi = {10.1002/mco2.71146}
}
Kostenlos starten →